+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Healthcare Contract Development & Manufacturing Organization Market by Service Type, Product Type, Process Type, End User, Scale, Technology, Therapeutic Area - Global Forecast to 2030- Product Image
Healthcare Contract Development & Manufacturing Organization Market by Service Type, Product Type, Process Type, End User, Scale, Technology, Therapeutic Area - Global Forecast to 2030- Product Image
Sale

Healthcare Contract Development & Manufacturing Organization Market by Service Type, Product Type, Process Type, End User, Scale, Technology, Therapeutic Area - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5456956
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Healthcare Contract Development & Manufacturing Organization (CDMO) market is transforming rapidly as pharmaceutical and biotech innovators seek outsized value from partners who enable flexible, compliant, and scalable drug development. This trend is intensifying as businesses respond to shifting regulatory demands, evolving technologies, and the pressure to expedite product pipelines while sustaining operational resilience.

Market Snapshot: Healthcare CDMO Market Growth and Dynamics

The Healthcare Contract Development & Manufacturing Organization Market grew from USD 331.99 billion in 2024 to USD 362.80 billion in 2025. It is expected to continue growing at a CAGR of 8.93%, reaching USD 554.90 billion by 2030. Expansion is propelled by rising complexity in drug modalities, surge in advanced therapies, and the shift toward outsourced models for efficient, compliant development and manufacturing. Innovation across biologics, small molecules, and next-generation modalities is driving demand for sophisticated CDMO services. Geopolitical shifts and supply chain challenges are also reshaping partnership models and capacity distribution globally.

Scope & Segmentation: Comprehensive Industry Coverage

This report delivers insight across the full landscape of the healthcare CDMO industry, positioning senior decision-makers to identify strategic opportunities and manage risk.

  • Service Types: Analytical services, drug product services, drug substance services, fill-finish services, packaging services
  • Product Types: Biologics (monoclonal antibodies, recombinant proteins, vaccines), small molecules
  • Process Types: Chemical synthesis, mammalian cell culture (batch, fed-batch, perfusion), microbial fermentation, viral vector manufacturing
  • End Users: Biotechnology companies, generic drug manufacturers, pharmaceutical companies
  • Scale: Clinical stage services, commercial manufacturing
  • Technologies: Single-use systems, traditional stainless steel platforms
  • Therapeutic Areas: Cardiology, infectious disease, neurology, oncology
  • Geographical Coverage: Americas (including United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (covering United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Company Profiles: Thermo Fisher Scientific Inc., Catalent, Inc., Lonza Group Ltd., Samsung Biologics Co., Ltd., WuXi AppTec Co., Ltd., Boehringer Ingelheim Pharma GmbH & Co. KG, Recipharm AB, Fujifilm Diosynth Biotechnologies, Inc., Novasep Holding S.A.S., AGC Biologics, Inc.

Key Takeaways: Strategic Insights for Decision-Makers

  • Increasing technology integration—including advanced analytics, digital twins, and process automation—is enhancing responsiveness and quality while supporting the scale-up of complex products.
  • Adoption of single-use systems is driving operational flexibility, particularly for multi-product and multi-modality manufacturing, supporting both established and emerging therapy formats.
  • Growth in cell and gene therapies necessitates investment in specialized manufacturing and quality platforms, positioning CDMOs able to handle high-containment and modular processes to capture premium segments.
  • Environmental sustainability is moving from regulatory compliance to a core differentiator, as CDMOs embed water and energy efficiency, waste minimization, and green chemistry practices into their operations.
  • Diversification of sourcing strategies and investment in supplier redundancy are vital in mitigating global supply chain risks and responding to evolving tariffs and trade regulations.
  • Strategic partnerships, such as co-development and risk-sharing agreements, are aligning incentives and accelerating technological adoption across the value chain.

Tariff Impact: Navigating the 2025 U.S. Tariff Wave

Recent U.S. tariff recalibrations targeting key raw materials and single-use components have increased input costs and added new complexity and administrative requirements for CDMOs operating cross-border. Companies are actively pivoting by renegotiating supplier contracts, exploring domestic and nearshore sourcing, and introducing in-house customs expertise to minimize production disruptions. Proactive financial modeling now includes tariff scenario planning, supporting greater agility in capital allocation and pricing structures.

Methodology & Data Sources

This analysis draws on a blend of primary interviews with CDMO, pharmaceutical, and regulatory executives, corroborated by reviews of industry reports, regulatory filings, and financial statements. Data integrity was ensured through triangulation, and all insights are based on validated industry evidence and expert peer review.

Why This Report Matters

  • Enables data-driven decision making by providing actionable intelligence on technology and process trends shaping the CDMO landscape.
  • Equips leaders to navigate supply chain risks, regulatory requirements, and region-specific strategic opportunities.
  • Supports partnership selection and investment prioritization in a complex, evolving market.

Conclusion

This report empowers senior stakeholders with the strategic clarity needed to adapt and thrive in the changing healthcare CDMO environment. With comprehensive coverage and actionable guidance, it is a vital tool for advancing competitive positioning and long-term growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Healthcare Contract Development & Manufacturing Organization Market, by Service Type
8.1. Introduction
8.2. Analytical Services
8.2.1. Bioanalytical Testing
8.2.2. Method Development
8.2.3. Stability Studies
8.3. Drug Product Services
8.4. Drug Substance Services
8.5. Fill Finish Services
8.6. Packaging Services
9. Healthcare Contract Development & Manufacturing Organization Market, by Product Type
9.1. Introduction
9.2. Biologics
9.2.1. Monoclonal Antibodies
9.2.2. Recombinant Proteins
9.2.3. Vaccines
9.3. Small Molecules
10. Healthcare Contract Development & Manufacturing Organization Market, by Process Type
10.1. Introduction
10.2. Chemical Synthesis
10.3. Mammalian Cell Culture
10.3.1. Batch Culture
10.3.2. Fed Batch Culture
10.3.3. Perfusion Culture
10.4. Microbial Fermentation
10.5. Viral Vector Manufacturing
11. Healthcare Contract Development & Manufacturing Organization Market, by End User
11.1. Introduction
11.2. Biotechnology Companies
11.3. Generic Drug Manufacturers
11.4. Pharmaceutical Companies
12. Healthcare Contract Development & Manufacturing Organization Market, by Scale
12.1. Introduction
12.2. Clinical Stage Services
12.3. Commercial Manufacturing
13. Healthcare Contract Development & Manufacturing Organization Market, by Technology
13.1. Introduction
13.2. Single Use Systems
13.3. Traditional Stainless Steel
14. Healthcare Contract Development & Manufacturing Organization Market, by Therapeutic Area
14.1. Introduction
14.2. Cardiology
14.3. Infectious Disease
14.4. Neurology
14.5. Oncology
15. Americas Healthcare Contract Development & Manufacturing Organization Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Healthcare Contract Development & Manufacturing Organization Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Healthcare Contract Development & Manufacturing Organization Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Thermo Fisher Scientific Inc.
18.3.2. Catalent, Inc.
18.3.3. Lonza Group Ltd.
18.3.4. Samsung Biologics Co., Ltd.
18.3.5. WuXi AppTec Co., Ltd.
18.3.6. Boehringer Ingelheim Pharma GmbH & Co. KG
18.3.7. Recipharm AB
18.3.8. Fujifilm Diosynth Biotechnologies, Inc.
18.3.9. Novasep Holding S.A.S.
18.3.10. AGC Biologics, Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET MULTI-CURRENCY
FIGURE 2. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET MULTI-LANGUAGE
FIGURE 3. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 20. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY METHOD DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY STABILITY STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY DRUG PRODUCT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY DRUG SUBSTANCE SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY FILL FINISH SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PACKAGING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BATCH CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY FED BATCH CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PERFUSION CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MICROBIAL FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY VIRAL VECTOR MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY GENERIC DRUG MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CLINICAL STAGE SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SINGLE USE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TRADITIONAL STAINLESS STEEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 70. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 71. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 73. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 74. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 75. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 77. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. CANADA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 79. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 80. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 81. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 83. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 84. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 85. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. MEXICO HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 130. GERMANY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 131. GERMANY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 132. GERMANY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. GERMANY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 134. GERMANY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 135. GERMANY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 136. GERMANY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. GERMANY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 138. GERMANY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. GERMANY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 140. FRANCE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 141. FRANCE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 142. FRANCE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. FRANCE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 144. FRANCE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 145. FRANCE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 146. FRANCE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. FRANCE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. FRANCE HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 160. ITALY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 161. ITALY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 162. ITALY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. ITALY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 164. ITALY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 165. ITALY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 166. ITALY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. ITALY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 168. ITALY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. ITALY HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 170. SPAIN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 171. SPAIN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 172. SPAIN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. SPAIN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 174. SPAIN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 175. SPAIN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 176. SPAIN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. SPAIN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 178. SPAIN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. SPAIN HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 210. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 211. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 212. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 214. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 215. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 216. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 218. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. DENMARK HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 230. QATAR HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 231. QATAR HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY ANALYTICAL SERVICES, 2018-2030 (USD MILLION)
TABLE 232. QATAR HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. QATAR HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 234. QATAR HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 235. QATAR HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 236. QATAR HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. QATAR HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 238. QATAR HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 20

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Healthcare Contract Development & Manufacturing Organization market report include:
  • Thermo Fisher Scientific Inc.
  • Catalent, Inc.
  • Lonza Group Ltd.
  • Samsung Biologics Co., Ltd.
  • WuXi AppTec Co., Ltd.
  • Boehringer Ingelheim Pharma GmbH & Co. KG
  • Recipharm AB
  • Fujifilm Diosynth Biotechnologies, Inc.
  • Novasep Holding S.A.S.
  • AGC Biologics, Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 362.8 Billion
Forecasted Market Value ( USD ) by 2030 $ 554.9 Billion
Compound Annual Growth Rate8.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Biologics Contract Development & Manufacturing Organization Market by Service Type, Expression System, Therapeutic Category, Development Phase, End User - Global Forecast to 2030 - Product Image

Biologics Contract Development & Manufacturing Organization Market by Service Type, Expression System, Therapeutic Category, Development Phase, End User - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Healthcare Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Services (Contract Development, Contract Manufacturing), By Region (Europe, APAC), And Segment Forecasts, 2024 - 2030 - Product Image

Healthcare Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Services (Contract Development, Contract Manufacturing), By Region (Europe, APAC), And Segment Forecasts, 2024 - 2030

  • Report
  • 145 Pages
  • Global
From
Healthcare Contract Development and Manufacturing Organization - Global Strategic Business Report - Product Image

Healthcare Contract Development and Manufacturing Organization - Global Strategic Business Report

  • Report
  • 117 Pages
  • Global
From
Antibody Contract Development and Manufacturing Organization - Global Strategic Business Report - Product Image

Antibody Contract Development and Manufacturing Organization - Global Strategic Business Report

  • Report
  • 276 Pages
  • Global
From
Antibody Contract Development And Manufacturing Organization - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Antibody Contract Development And Manufacturing Organization - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.